Sonova Holding (OTCMKTS:SONVY – Get Free Report) was the target of a large increase in short interest in October. As of October 30th, there was short interest totaling 58,939 shares, an increase of 428.2% from the October 15th total of 11,158 shares. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 52,624 shares, the days-to-cover ratio is presently 1.1 days.
Wall Street Analysts Forecast Growth
Several research analysts have commented on SONVY shares. UBS Group cut shares of Sonova from a “strong-buy” rating to a “hold” rating in a report on Monday, November 2nd. Citigroup reaffirmed a “sell” rating on shares of Sonova in a research note on Friday, July 24th. The Goldman Sachs Group raised Sonova from a “hold” rating to a “buy” rating in a research report on Thursday, October 8th. Finally, Royal Bank Of Canada lowered shares of Sonova from a “moderate buy” rating to a “hold” rating in a research note on Friday, November 6th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Sonova currently has an average rating of “Hold”.
Get Our Latest Analysis on SONVY
Sonova Stock Down 0.2%
Shares of SONVY traded down $0.10 during trading hours on Wednesday, reaching $68.14. 3,962 shares of the company traded hands, compared to its average volume of 29,807. The stock’s fifty day moving average is $62.62 and its 200 day moving average is $53.71. The company has a quick ratio of 1.43, a current ratio of 1.75 and a debt-to-equity ratio of 0.51. Sonova has a 1-year low of $42.26 and a 1-year high of $71.91.
About Sonova
Sonova is a Switzerland-based hearing care company headquartered in Stäfa. Founded in 1947 as AG für Elektroakustik, it has grown into a global provider of products and services for people with hearing loss. The company develops and sells hearing aids under brands including Phonak and Unitron, as well as cochlear implant systems through Advanced Bionics. Its offerings also include wireless hearing solutions and consumer audio products sold under the Sennheiser brand. Sonova serves customers worldwide through product sales and audiological care services, including hearing assessments, fittings and ongoing support.
See Also
- Five stocks we like better than Sonova
- Why Apple Stock Looks Like a Safe Haven After the Midterms
- IonQ Raised the Bar, But 3 Quantum Rivals Face Tough Questions
- On Holding’s Sell-Off Overlooks a Key Part of Its Earnings Story
- Aehr Test Systems Notches Another Post-Earnings Win as Sales Triple on AI Demand
Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.
